Professor Eleanor Stride is Professor of Engineering Science at the Institute of Biomedical Engineering, University of Oxford. From 2005 to 2010, she held a Royal Academy of Engineering Research Fellowship, which enabled her to investigate the development of novel microbubble agents for use in the detection and treatment of cancer. She was elected as an Academy Fellow at the Royal Academy of Engineering in 2017.
Professor Stride's Research Fellowship allowed her to build on an interest in ultrasound therapy and the use of microbubbles for targeted drug use define her own research objectives while at University College London (UCL).
Her research into micro- and nano-encapsulation led to establishing her first spin-out company, AtoCap Ltd, alongside collaborators. The company currently focuses on the delivery of antibiotics for the treatment of chronic conditions.
After being offered a Readership at the end of her Fellowship, Professor Stride now leads a research group that includes eight PhD students, eight postdoctoral students and four master’s project students. She has achieved this by leveraging funding from the Engineering and Physical Sciences Research Council, among others. “The reputation of the Academy and the Fellowship has undoubtedly been valuable in my subsequent applications for grant funding,” she explains.
“My Research Fellowship laid the foundations for my research career and was invaluable in enabling me to build up the expertise, networks and resources to become an independent researcher.”
Professor Eleanor Stride